SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

Disaggregate revenue

The following tables disaggregate revenue by source (in thousands):

	Three Months Ended September 30, 2019
	Medical and		Financial		Home Office
	Healthcare		Services		and Other		Consolidated
Higher Education	$	201,453	$	—	$	—	$	201,453
Test Preparation/Certifications		—		24,972		—		24,972
Conferences/Seminars		—		17,070		—		17,070
Memberships/Subscriptions		—		4,867		—		4,867
Other		6,034		217		—		6,251
Total	$	207,487	$	47,126	$	—	$	254,613

	Three Months Ended September 30, 2018
	Medical and		Financial		Home Office
	Healthcare		Services		and Other		Consolidated
Higher Education	$	201,173	$	—	$	—	$	201,173
Test Preparation/Certifications		—		28,716		(807)		27,909
Conferences/Seminars		—		2,868		—		2,868
Memberships/Subscriptions		—		3,936		—		3,936
Other		927		126		—		1,053
Total	$	202,100	$	35,646	$	(807)	$	236,939

Reconciliation of Non-Controlling Interest Balance

The following is a reconciliation of the noncontrolling interest balance (in thousands):

	Three Months Ended
	September 30,
	2019		2018
Balance at Beginning of Period	$	9,543	$	9,110
Net Loss Attributable to Noncontrolling Interest		(109)		(55)
Decrease in Redemption Value of Noncontrolling Interest Put Option		—		(241)
Payment for Purchase of Noncontrolling Interest of Subsidiary		(6,247)		—
Balance at End of Period	$	3,187	$	8,814

Reconciliation of Basic Shares to Diluted Shares

The following is a reconciliation of basic shares to diluted shares (in thousands):

	Three Months Ended
	September 30,
	2019	2018
Weighted Average Shares Outstanding	55,018	59,722
Unvested Participating RSUs	475	606
Basic Shares	55,493	60,328
Effect of Dilutive Stock Options	647	874
Diluted Shares	56,140	61,202

Summary of impact on the Consolidated Balance Sheet upon adoption of ASC 842

	June 30,		Adjustments due to		July 1,
	2019		adoption of ASC 842		2019
	(in thousands, except share and par value amounts)
ASSETS:
Current Assets:
Cash and Cash Equivalents	$	299,445	$	—	$	299,445
Investments in Marketable Securities		8,680		—		8,680
Restricted Cash		1,022		—		1,022
Accounts Receivable, Net		157,829		—		157,829
Prepaid Expenses and Other Current Assets		37,724		(3,483)		34,241
Total Current Assets		504,700		(3,483)		501,217
Land, Building and Equipment:
Land		44,609		—		44,609
Building		383,331		—		383,331
Equipment		281,551		—		281,551
Construction in Progress		16,222		—		16,222
		725,713		—		725,713
Accumulated Depreciation		(361,030)		—		(361,030)
Land, Building and Equipment, Net		364,683		—		364,683
Noncurrent Assets:
Operating Lease Assets		—		282,978		282,978
Deferred Income Taxes		18,314		—		18,314
Intangible Assets, Net		418,097		—		418,097
Goodwill		874,451		—		874,451
Other Assets, Net		62,451		—		62,451
Total Noncurrent Assets		1,373,313		282,978		1,656,291
TOTAL ASSETS	$	2,242,696	$	279,495	$	2,522,191
LIABILITIES:
Current Liabilities:
Accounts Payable	$	57,627	$	—	$	57,627
Accrued Salaries, Wages and Benefits		64,492		—		64,492
Accrued Liabilities		86,722		(16,946)		69,776
Deferred Revenue		99,790		—		99,790
Current Operating Lease Liabilities		—		66,707		66,707
Current Portion of Long-Term Debt		3,000		—		3,000
Total Current Liabilities		311,631		49,761		361,392
Noncurrent Liabilities:
Long-Term Debt		398,094		—		398,094
Long-Term Operating Lease Liabilities		—		269,387		269,387
Deferred Income Taxes		29,426		—		29,426
Other Liabilities		102,472		(39,653)		62,819
Total Noncurrent Liabilities		529,992		229,734		759,726
TOTAL LIABILITIES		841,623		279,495		1,121,118
NONCONTROLLING INTEREST		9,543		—		9,543
SHAREHOLDERS’ EQUITY:
Common Stock, $0.01 Par Value		801		—		801
Additional Paid-in Capital		486,061		—		486,061
Retained Earnings		2,012,902		—		2,012,902
Accumulated Other Comprehensive Loss		(137,290)		—		(137,290)
Treasury Stock, at Cost		(970,944)		—		(970,944)
TOTAL SHAREHOLDERS’ EQUITY		1,391,530		—		1,391,530
TOTAL LIABILITIES, NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY	$	2,242,696	$	279,495	$	2,522,191